Jon Kindblom

Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial

Anders Widmark, Adalsteinn Gunnlaugsson, L. Beckman et al. · The Lancet · 2019 · 871 citations

Medicine, Radiation Oncology, Urology +16

Prolactin and growth hormone regulate adiponectin secretion and receptor expression in adipose tissue

L. V. Nilsson, Nadine Binart, Mohammad Bohlooly‐Y et al. · Biochemical and Biophysical Research Communications · 2005 · 189 citations

Life Sciences, Endocrinology, Physiology +16

Transgenic Mice Overexpressing the Prolactin Gene Develop Dramatic Enlargement of the Prostate Gland¹

Håkan Wennbo, Jon Kindblom, Olle Isaksson et al. · Endocrinology · 1997 · 187 citations · Full text

Medicine, Endocrinology, Urology +15

Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer (HYPO-RT-PC): patient-reported quality-of-life outcomes of a randomised, controlled, non-inferiority, phase 3 trial

Per Fransson, Per Nilsson, Adalsteinn Gunnlaugsson et al. · The Lancet Oncology · 2021 · 157 citations

Medicine, Oncology, Radiation Oncology +17

Prostate Hyperplasia in a Transgenic Mouse with Prostate-Specific Expression of Prolactin

Jon Kindblom, Karin Dillner, Lena Sahlin et al. · Endocrinology · 2003 · 114 citations · Full text

Medicine, Endocrinology, Urology +16